UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Category: Published Research

Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany

JAMA – Question  Is SARS-CoV-2 seropositivity associated with symptoms of myalgic encephalomyelitis and/or chronic fatigue syndrome (ME/CFS) in children and adolescents? Findings  This cross-sectional study of hospital-based SARS-CoV-2 seroprevalence surveys in Germany compared seropositive and seronegative children and adolescents and identified an excess of possible ME/CFS symptoms with serological evidence of preceding SARS-CoV-2 infection. This association almost […]

Sep 28, 2022

Remdesivir resistance in transplant recipients with persistent COVID-19

Clinical Infectious Diseases – New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical implications. We describe the first cases of an independently acquired V792I RNA-dependent RNA polymerase mutation developing in renal transplant recipients after remdesivir exposure. Our work underscores the need for augmented efforts to identify concerning mutations and address their clinical implications. Download […]

Sep 28, 2022

Increase in Acute Respiratory Illnesses Among Children and Adolescents Associated with Rhinoviruses and Enteroviruses, Including Enterovirus D68 — United States, July–September 2022

CDC – Increases in severe respiratory illness and acute flaccid myelitis (AFM) among children and adolescents resulting from enterovirus D68 (EV-D68) infections occurred biennially in the United States during 2014, 2016, and 2018, primarily in late summer and fall. Although EV-D68 annual trends are not fully understood, EV-D68 levels were lower than expected in 2020, […]

Sep 28, 2022

Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants

The Lancet – SARS-CoV-2 BA.4 and BA.5 lineages have been the dominant strains in most regions worldwide and are continuously gaining mutations in the receptor-binding domain. Multiple BA.4 and BA.5 subvariants with Arg346 mutations in the spike glycoprotein have been identified in various countries, such as BA.4.6, BF.7, BA.5.2.6, BA.4.1.9, and BE.1.2 harbouring Arg346Thr; BA.4.7 […]

Sep 28, 2022

Host and viral proteins involved in SARS-CoV-2 infection differentially bind heme

PubMed – In most severe cases, SARS-CoV-2-induced autoimmune reactions have been associated with hemolytic complications. Hemolysis-derived heme from ruptured red blood cells has been shown to trigger a variety of fatal proinflammatory and procoagulant effects, which might deteriorate the progression of COVID-19. In addition, the virus itself can induce proinflammatory signals via the accessory protein […]

Sep 28, 2022

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

Nature – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus Betacoronavirus. The ancestor strain has evolved into a number of variants of concern, with the Omicron variant of concern now having many distinct sublineages. The ongoing COVID-19 pandemic caused by […]

Sep 28, 2022

A practical update on the management of patients with COVID–19

Royal College of Physicians – While vaccines against COVID-19 are being rolled out, an ongoing need remains for therapies to treat patients who have symptomatic COVID-19 before vaccination or in whom breakthrough infection develops. Dexamethasone and interleukin-6 inhibitors have been the mainstay of treatment for severe to critical COVID-19 requiring hospitalisation. However, in the previous […]

Sep 27, 2022

Hybrid immunity and strategies for COVID-19 vaccination

The Lancet Infectious Diseases – Since April, 2022, BA.2.12.1, BA.4, and BA.5 subvariants of the omicron (B.1.1.529) SARS-CoV-2 variant of concern have been spreading globally with increased viral fitness and transmissibility. Omicron BA.5 subvariant is currently the predominant COVID-19 threat worldwide. With the emergence of the antigenically distinct variants of concern, either natural immunity or […]

Sep 27, 2022

COVID-19 Patient Characteristics and Time to Viral Clearance: A Retrospective Observational Study in a Multiethnic Population (UAE)

Journal of Clinical Virology – The factors contributing to delayed viral clearance in COVID-19 are still unclear.•The authors investigated these factors in a study of a multiethnic population.• Advanced age, cardiovascular comorbidity, and severe COVID-19 all led to Delayed viral clearance• This early recognition enables for a detailed strategy to optimize the outcome.

Sep 27, 2022

Test predicts which COVID-19 patients will grow worse, Stanford Medicine study find

Stanford Medicine – Elevated virus levels in hospitalized COVID-19 patients’ blood predicts worsening respiratory symptoms and suggests ongoing viral replication in later disease stages, Stanford Medicine-led study says. A one-time test could predict which people hospitalized with COVID-19 are likely to worsen significantly during their stay, even if they were admitted with relatively mild symptoms, […]

Sep 26, 2022

XR PWRQbX Gg rPgI Lny D